"False"
Skip to content
printicon
Main menu hidden.

Molecular medicine

Latest news

Oliver BillkerProfessor vid Institutionen för molekylärbiologiEnhet: Grupp Oliver BillkerAnknuten som forskare till Molekylär Infektionsmedicin, Sverige (MIMS)Roll: Föreståndare
Oliver Billker awarded the Torgny och Lena Stigbrand Prize

Receives the award for his pioneering work in malaria research.

Sun Nyunt Wai
Sun Nyunt Wai awarded for outstanding bacterial research

Professor Sun Nyunt Wai is awarded the Bo and Barbro Hammarström Prize in 2026.

Anna Överby Wernstedt
2025 MIMS Investigator Award Announcement

MIMS announces four recipients of the 2025 MIMS Investigator Award.

Grafik
Discovery on how aggressive breast cancer controls protein production

A mechanism that increases our understanding of how breast tumours grow and adapt has been discovered.

Exciting findings from an antibiotic discovery project with labhead Barbara Sixt and colleague Aakriti Singh and Magnus Ölander, postdoc in the Sixtlab,
Barbara Sixt awarded ERC Consolidator Grant

ERC provides funding for five years to Barbara Sixt's research on chlamydia.

En kvinna med långt blont hår står i snön.
MIMS Spotlight Series: Louise meets Sanja Vanhatalo

Meet Sanja Vanhatalo, a postdoc in Björn Schröder's lab who studies microbiota and inflammatory bowel disease.

Features

Illustration gensax
CRISPR-Cas9 – the gene-editing tool that changed the world

A breakthrough in Umeå laid the foundation for CRISPR-Cas9, a revolutionary tool.

Elin Chorell, forskare vid Institutionen för folkhälsa och klinisk medicin, Umeå universitet.
Aiming to detect and halt type 2 diabetes

Her goal is to make it possible to detect and slow the progression of type 2 diabetes at an early stage.

Gut bacteria can provide clues to curing diseases

André Mateus researches how drugs and the microbiome in the human gut work together.

Four-stranded DNA in a new type of cancer therapy

Nasim Sabouris research findings are forming the basis for efforts to develop new cancer therapeutics.

Targeting cancer cells without affecting healthy cells

Francesca Aguilos work lies at the cutting edge of biomedical research and cancer.

Charpentier: "I really miss the atmosphere at Umeå University"

Words of praise, memories and laughter. Celebrating Umeå's first Nobel laureate via a live web link.

Research groups

Martin Cohn group
Maintenance of genomic stability and DNA repair in humans.
Matthew Francis Lab
Francis' laboratory aims to understand the physiology and pathogenesis of bacteria.
Monica Holmberg Lab
The most important goal of our research is to understand the specific processes involved in hereditary diseases, especially neurological and...
Research area: Molecular medicine
Per Stål-research group
Our group is dedicated to translational research on healthy and pathological skeletal and cardiac muscles. The research areas cover studies of musc...
Richard Lundmark
Membrane sculpting is fundamental for many cellular processes, and malfunction is implicated in many diseases.
Ryo Morimoto Lab
Studying processes that drive the diversification of antigen recognition molecules in the immune system.
Sara Wilson
The goal of the laboratory is to examine the growth, assembly and connectivity of the nervous system during normal development and in disease...
Saskia Erttmann Lab
Unraveling the molecular mechanisms during the microbial-driven onset and resolution of inflammation
Silvia Remeseiro
We study long-range gene regulation and 3D organization of the glioblastoma genome.
Simon Tuck lab
Nutrient-dependent control of growth in c. elegans
Research area: Cancer, Molecular medicine
Sophia Harlid´s research group
We study the connection between our environment, our genes and our health.
Teresa Frisan Lab
We study the role of bacterial genotoxins in modulation of intestinal mucosa homeostasis.
Ulf Ahlgren
More on grp Ulf Ahlgrens ongoing research.
Research area: Molecular medicine

Research projects

High-speed mid-infrared photothermal imaging of fatty acids and lipid droplets in living cells
Duration 1 January 2023 until 31 December 2026
Type of project Research project
Development of a new tularemia vaccine
Duration 1 January 2021 until 31 December 2025
Type of project Research project
Prostate cancer therapy for COVID-19
Duration 8 June 2020 until 31 May 2022
Type of project Research project
Artificial intelligence in oncology: European REVERT
Duration 1 January 2020 until 31 December 2023
Type of project Research project
Mosquito-borne zoonosis in animals and humans
Research area: Molecular medicine
Duration 1 January 2015 until 31 December 2017
Type of project Research project
Neuromuscular injuries in Obstructive Sleep Apnea
Duration 10 October 2013
Type of project Research project
CD47 and signal regulatory protein a (SIRP a) modulates innate immune and autoimmune responses
Research area: Molecular medicine
Duration 28 October 2011 until 31 December 2013
Type of project Research project